A new review of nearly 100,000 participants suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs), popular ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

Semaglutide — the active ingredient in Ozempic® — causes thyroid tumors in rodents. But it’s unclear if this happens in humans. Currently, research hasn’t found a link between Ozempic® and any type of ...

COPENHAGEN (Reuters) -A thyroid cancer safety signal was raised by the EU's drugs watchdog last month over several Novo Nordisk products including semaglutide, which is used in popular diabetes and ...

GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, ...

Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...

SYDNEY, AUSTRALIA - JANUARY 13: Ozempic is medicine for adults with type 2 diabetes . Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient ...